![Frontiers | Withholding vs. Continuing Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Before Non-cardiac Surgery in Older Patients: Study Protocol for a Multicenter Randomized Controlled Trial Frontiers | Withholding vs. Continuing Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Before Non-cardiac Surgery in Older Patients: Study Protocol for a Multicenter Randomized Controlled Trial](https://www.frontiersin.org/files/MyHome%20Article%20Library/654700/654700_Thumb_400.jpg)
Frontiers | Withholding vs. Continuing Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Before Non-cardiac Surgery in Older Patients: Study Protocol for a Multicenter Randomized Controlled Trial
![Chronotherapy With the Angiotensin-Converting Enzyme Inhibitor Ramipril in Essential Hypertension | Hypertension Chronotherapy With the Angiotensin-Converting Enzyme Inhibitor Ramipril in Essential Hypertension | Hypertension](https://www.ahajournals.org/cms/asset/e0d989fa-e1f6-4222-bd57-efdd1fed9e4e/23ff3.jpg)
Chronotherapy With the Angiotensin-Converting Enzyme Inhibitor Ramipril in Essential Hypertension | Hypertension
![Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension—Pro Side of the Argument | Hypertension Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension—Pro Side of the Argument | Hypertension](https://www.ahajournals.org/cms/asset/45ac5d40-1660-483f-a901-5741384d20f4/hypertensionaha.120.16500.fig01.jpg)
Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension—Pro Side of the Argument | Hypertension
![Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet](https://www.thelancet.com/cms/asset/8e2715b8-4a0b-4717-ac70-7d7ee212f889/gr1.jpg)
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet
Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety | PLOS ONE
Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety | PLOS ONE
![Kaplan USMLE Step 1 prep: Replacing which medication will improve symptoms? | American Medical Association Kaplan USMLE Step 1 prep: Replacing which medication will improve symptoms? | American Medical Association](https://www.ama-assn.org/sites/ama-assn.org/files/2020-12/step1medication_inset.jpg)
Kaplan USMLE Step 1 prep: Replacing which medication will improve symptoms? | American Medical Association
![Design, formulation and evaluation of multiparticulate time programmed system of ramipril for pulsed release: An approach in the management of early morning surge in blood pressure - ScienceDirect Design, formulation and evaluation of multiparticulate time programmed system of ramipril for pulsed release: An approach in the management of early morning surge in blood pressure - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1773224721000253-fx1.jpg)